Brief: Central Huijin's Long Position In Sciclone Pharmaceuticals Falls To 7.69% - HKEX Filing
March 15 (Reuters) - Hong Kong stock exchange filing:
* CENTRAL HUIJIN INVESTMENT LTD'S LONG POSITION IN SCICLONE
PHARMACEUTICALS 6600.HK REDUCED TO 7.69% ON MARCH 10 FROM
11.32% - HKEX FILING
Source text
Further company coverage: 6600.HK
(Reporting by Hong Kong newsroom)
((twinnie.siu@tr.com; 852-3462 7715;))
Recent news on SciClone Pharmaceuticals (Holdings)
See all newsOneRobotics surges on plan to buy more shares
Brief: Onerobotics (Shenzhen) To Procure Affiliate Of Co To Acquire 59.9% Stake Of Nanoleaf Limited, Others
Brief: OneRobotics (Shenzhen) Says Final Offer Price Under Global Offering Is HK$73.80 Per H Share
Brief: Sciclone Pharmaceuticals (Holdings) Announces Proposal For Privatisation Of Co By Silver Pegasus Investment
Brief: SciClone Pharmaceuticals Says Trading In Shares Halted